These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nitric oxide and cancer therapy: the emperor has NO clothes. Hickok JR; Thomas DD Curr Pharm Des; 2010; 16(4):381-91. PubMed ID: 20236067 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Hirst D; Robson T Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Mocellin S; Bronte V; Nitti D Med Res Rev; 2007 May; 27(3):317-52. PubMed ID: 16991100 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives. Seabra AB; de Lima R; Calderón M Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351 [TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029 [TBL] [Abstract][Full Text] [Related]
9. NO Wang J; Hussain SP Antioxid Redox Signal; 2017 Jun; 26(17):1000-1008. PubMed ID: 27510096 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma. Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Kwon G; Bohrer A; Han X; Corbett JA; Ma Z; Gross RW; McDaniel ML; Turk J Biochim Biophys Acta; 1996 Mar; 1300(1):63-72. PubMed ID: 8608164 [TBL] [Abstract][Full Text] [Related]